APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atropine Sulfate for Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Atropine Sulfate for Injection Market Analysis and Forecast 2026-2032

26 December 2025203 pages

Choose your research edition.

Industry ResearchAtropine Sulfate for Injection Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Atropine Sulfate for Injection Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Atropine Sulfate for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atropine Sulfate for Injection Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Atropine Sulfate for Injection Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Atropine Sulfate for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Atropine Sulfate for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Atropine Sulfate for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Atropine Sulfate for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Atropine Sulfate for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Atropine Sulfate for Injection include Accord Healthcare, American Regent, Amneal Pharmaceuticals, Apotex, Hikma Pharmaceuticals, Anhui Changjiang Pharmaceutical, Changzhou Pharmaceutical Factory, Chengdu Brilliant Pharmaceutical and Hebei Kaiwei Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Atropine Sulfate for Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Atropine Sulfate for Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Atropine Sulfate for Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Atropine Sulfate for Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Atropine Sulfate for Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Atropine Sulfate for Injection sales, projected growth trends, production technology, application and end-user industry.

Atropine Sulfate for Injection Segment by Company

Accord Healthcare

American Regent

Amneal Pharmaceuticals

Apotex

Hikma Pharmaceuticals

Anhui Changjiang Pharmaceutical

Changzhou Pharmaceutical Factory

Chengdu Brilliant Pharmaceutical

Hebei Kaiwei Pharmaceutical

Hebei Tiancheng Pharmaceutical

Hubei Xinghua Pharmaceutical

China Res Double-Crane

Pfizer

Sunflower Pharmaceutical

Shanghai Harvest Pharmaceutical

China Shineway Pharm

CSPC Ouyi Pharmaceutical

Suicheng Pharmaceutical

Tai Yu Chemical & Pharmaceutical

Tianjin Jinyao Pharmaceutical

Atropine Sulfate for Injection Segment by Type

0.5 mg/mL

1 mg/mL

5 mg/ml

Others

Atropine Sulfate for Injection Segment by Application

Online Sales

Offline Sales

Atropine Sulfate for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atropine Sulfate for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atropine Sulfate for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atropine Sulfate for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Atropine Sulfate for Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Atropine Sulfate for Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Atropine Sulfate for Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Atropine Sulfate for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.5 mg/mL Major Manufacturers Table 3. 1 mg/mL Major Manufacturers Table 4. 5 mg/ml Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Atropine Sulfate for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Online Sales Major Manufacturers Table 8. Offline Sales Major Manufacturers Table 9. Atropine Sulfate for Injection Industry Trends Table 10. Atropine Sulfate for Injection Industry Drivers Table 11. Atropine Sulfate for Injection Industry Opportunities and Challenges Table 12. Atropine Sulfate for Injection Industry Restraints Table 13. Global Atropine Sulfate for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Atropine Sulfate for Injection Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Atropine Sulfate for Injection Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Atropine Sulfate for Injection Revenue Market Share by Region (2021-2026) Table 17. Global Atropine Sulfate for Injection Revenue Market Share by Region (2027-2032) Table 18. Global Atropine Sulfate for Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Atropine Sulfate for Injection Sales by Region (2021-2026) & (K Units) Table 20. Global Atropine Sulfate for Injection Sales by Region (2027-2032) & (K Units) Table 21. Global Atropine Sulfate for Injection Sales Market Share by Region (2021-2026) Table 22. Global Atropine Sulfate for Injection Sales Market Share by Region (2027-2032) Table 23. Global Atropine Sulfate for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Atropine Sulfate for Injection Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Atropine Sulfate for Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Atropine Sulfate for Injection Sales Market Share by Manufacturers (2021-2026) Table 27. Global Atropine Sulfate for Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Atropine Sulfate for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Atropine Sulfate for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Atropine Sulfate for Injection Manufacturers, Product Type & Application Table 31. Global Atropine Sulfate for Injection Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Atropine Sulfate for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Atropine Sulfate for Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Atropine Sulfate for Injection Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Atropine Sulfate for Injection Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Atropine Sulfate for Injection Revenue Market Share by Type (2021-2026) Table 38. Global Atropine Sulfate for Injection Revenue Market Share by Type (2027-2032) Table 39. Global Atropine Sulfate for Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Atropine Sulfate for Injection Sales by Type (2021-2026) & (K Units) Table 41. Global Atropine Sulfate for Injection Sales by Type (2027-2032) & (K Units) Table 42. Global Atropine Sulfate for Injection Sales Market Share by Type (2021-2026) Table 43. Global Atropine Sulfate for Injection Sales Market Share by Type (2027-2032) Table 44. Global Atropine Sulfate for Injection Price by Type (2021-2026) & (US$/Unit) Table 45. Global Atropine Sulfate for Injection Price by Type (2027-2032) & (US$/Unit) Table 46. Global Atropine Sulfate for Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Atropine Sulfate for Injection Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Atropine Sulfate for Injection Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Atropine Sulfate for Injection Revenue Market Share by Application (2021-2026) Table 50. Global Atropine Sulfate for Injection Revenue Market Share by Application (2027-2032) Table 51. Global Atropine Sulfate for Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Atropine Sulfate for Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Atropine Sulfate for Injection Sales by Application (2027-2032) & (K Units) Table 54. Global Atropine Sulfate for Injection Sales Market Share by Application (2021-2026) Table 55. Global Atropine Sulfate for Injection Sales Market Share by Application (2027-2032) Table 56. Global Atropine Sulfate for Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Atropine Sulfate for Injection Price by Application (2027-2032) & (US$/Unit) Table 58. Accord Healthcare Company Information Table 59. Accord Healthcare Business Overview Table 60. Accord Healthcare Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Accord Healthcare Atropine Sulfate for Injection Product Portfolio Table 62. Accord Healthcare Recent Development Table 63. American Regent Company Information Table 64. American Regent Business Overview Table 65. American Regent Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. American Regent Atropine Sulfate for Injection Product Portfolio Table 67. American Regent Recent Development Table 68. Amneal Pharmaceuticals Company Information Table 69. Amneal Pharmaceuticals Business Overview Table 70. Amneal Pharmaceuticals Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Amneal Pharmaceuticals Atropine Sulfate for Injection Product Portfolio Table 72. Amneal Pharmaceuticals Recent Development Table 73. Apotex Company Information Table 74. Apotex Business Overview Table 75. Apotex Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Apotex Atropine Sulfate for Injection Product Portfolio Table 77. Apotex Recent Development Table 78. Hikma Pharmaceuticals Company Information Table 79. Hikma Pharmaceuticals Business Overview Table 80. Hikma Pharmaceuticals Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Hikma Pharmaceuticals Atropine Sulfate for Injection Product Portfolio Table 82. Hikma Pharmaceuticals Recent Development Table 83. Anhui Changjiang Pharmaceutical Company Information Table 84. Anhui Changjiang Pharmaceutical Business Overview Table 85. Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Product Portfolio Table 87. Anhui Changjiang Pharmaceutical Recent Development Table 88. Changzhou Pharmaceutical Factory Company Information Table 89. Changzhou Pharmaceutical Factory Business Overview Table 90. Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Product Portfolio Table 92. Changzhou Pharmaceutical Factory Recent Development Table 93. Chengdu Brilliant Pharmaceutical Company Information Table 94. Chengdu Brilliant Pharmaceutical Business Overview Table 95. Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Product Portfolio Table 97. Chengdu Brilliant Pharmaceutical Recent Development Table 98. Hebei Kaiwei Pharmaceutical Company Information Table 99. Hebei Kaiwei Pharmaceutical Business Overview Table 100. Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Product Portfolio Table 102. Hebei Kaiwei Pharmaceutical Recent Development Table 103. Hebei Tiancheng Pharmaceutical Company Information Table 104. Hebei Tiancheng Pharmaceutical Business Overview Table 105. Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Product Portfolio Table 107. Hebei Tiancheng Pharmaceutical Recent Development Table 108. Hubei Xinghua Pharmaceutical Company Information Table 109. Hubei Xinghua Pharmaceutical Business Overview Table 110. Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Product Portfolio Table 112. Hubei Xinghua Pharmaceutical Recent Development Table 113. China Res Double-Crane Company Information Table 114. China Res Double-Crane Business Overview Table 115. China Res Double-Crane Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. China Res Double-Crane Atropine Sulfate for Injection Product Portfolio Table 117. China Res Double-Crane Recent Development Table 118. Pfizer Company Information Table 119. Pfizer Business Overview Table 120. Pfizer Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Pfizer Atropine Sulfate for Injection Product Portfolio Table 122. Pfizer Recent Development Table 123. Sunflower Pharmaceutical Company Information Table 124. Sunflower Pharmaceutical Business Overview Table 125. Sunflower Pharmaceutical Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Sunflower Pharmaceutical Atropine Sulfate for Injection Product Portfolio Table 127. Sunflower Pharmaceutical Recent Development Table 128. Shanghai Harvest Pharmaceutical Company Information Table 129. Shanghai Harvest Pharmaceutical Business Overview Table 130. Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Product Portfolio Table 132. Shanghai Harvest Pharmaceutical Recent Development Table 133. China Shineway Pharm Company Information Table 134. China Shineway Pharm Business Overview Table 135. China Shineway Pharm Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. China Shineway Pharm Atropine Sulfate for Injection Product Portfolio Table 137. China Shineway Pharm Recent Development Table 138. CSPC Ouyi Pharmaceutical Company Information Table 139. CSPC Ouyi Pharmaceutical Business Overview Table 140. CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Product Portfolio Table 142. CSPC Ouyi Pharmaceutical Recent Development Table 143. Suicheng Pharmaceutical Company Information Table 144. Suicheng Pharmaceutical Business Overview Table 145. Suicheng Pharmaceutical Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Suicheng Pharmaceutical Atropine Sulfate for Injection Product Portfolio Table 147. Suicheng Pharmaceutical Recent Development Table 148. Tai Yu Chemical & Pharmaceutical Company Information Table 149. Tai Yu Chemical & Pharmaceutical Business Overview Table 150. Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Product Portfolio Table 152. Tai Yu Chemical & Pharmaceutical Recent Development Table 153. Tianjin Jinyao Pharmaceutical Company Information Table 154. Tianjin Jinyao Pharmaceutical Business Overview Table 155. Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Product Portfolio Table 157. Tianjin Jinyao Pharmaceutical Recent Development Table 158. North America Atropine Sulfate for Injection Revenue by Type (2021-2026) & (US$ Million) Table 159. North America Atropine Sulfate for Injection Revenue by Type (2027-2032) & (US$ Million) Table 160. North America Atropine Sulfate for Injection Sales by Type (2021-2026) & (K Units) Table 161. North America Atropine Sulfate for Injection Sales by Type (2027-2032) & (K Units) Table 162. North America Atropine Sulfate for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 163. North America Atropine Sulfate for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 164. North America Atropine Sulfate for Injection Revenue by Application (2021-2026) & (US$ Million) Table 165. North America Atropine Sulfate for Injection Revenue by Application (2027-2032) & (US$ Million) Table 166. North America Atropine Sulfate for Injection Sales by Application (2021-2026) & (K Units) Table 167. North America Atropine Sulfate for Injection Sales by Application (2027-2032) & (K Units) Table 168. North America Atropine Sulfate for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 169. North America Atropine Sulfate for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 170. North America Atropine Sulfate for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. North America Atropine Sulfate for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. North America Atropine Sulfate for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. North America Atropine Sulfate for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. North America Atropine Sulfate for Injection Sales by Country (2021-2026) & (K Units) Table 175. North America Atropine Sulfate for Injection Sales by Country (2027-2032) & (K Units) Table 176. North America Atropine Sulfate for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 177. North America Atropine Sulfate for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 178. United States Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 179. Canada Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 180. Mexico Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 181. Europe Atropine Sulfate for Injection Revenue by Type (2021-2026) & (US$ Million) Table 182. Europe Atropine Sulfate for Injection Revenue by Type (2027-2032) & (US$ Million) Table 183. Europe Atropine Sulfate for Injection Sales by Type (2021-2026) & (K Units) Table 184. Europe Atropine Sulfate for Injection Sales by Type (2027-2032) & (K Units) Table 185. Europe Atropine Sulfate for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 186. Europe Atropine Sulfate for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 187. Europe Atropine Sulfate for Injection Revenue by Application (2021-2026) & (US$ Million) Table 188. Europe Atropine Sulfate for Injection Revenue by Application (2027-2032) & (US$ Million) Table 189. Europe Atropine Sulfate for Injection Sales by Application (2021-2026) & (K Units) Table 190. Europe Atropine Sulfate for Injection Sales by Application (2027-2032) & (K Units) Table 191. Europe Atropine Sulfate for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 192. Europe Atropine Sulfate for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 193. Europe Atropine Sulfate for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Europe Atropine Sulfate for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Europe Atropine Sulfate for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Europe Atropine Sulfate for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 197. Europe Atropine Sulfate for Injection Sales by Country (2021-2026) & (K Units) Table 198. Europe Atropine Sulfate for Injection Sales by Country (2027-2032) & (K Units) Table 199. Europe Atropine Sulfate for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 200. Europe Atropine Sulfate for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 201. Germany Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 202. France Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 203. U.K. Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 204. Italy Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 205. Russia Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 206. Spain Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 207. Netherlands Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 208. Switzerland Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 209. Sweden Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 210. Poland Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 211. China Atropine Sulfate for Injection Revenue by Type (2021-2026) & (US$ Million) Table 212. China Atropine Sulfate for Injection Revenue by Type (2027-2032) & (US$ Million) Table 213. China Atropine Sulfate for Injection Sales by Type (2021-2026) & (K Units) Table 214. China Atropine Sulfate for Injection Sales by Type (2027-2032) & (K Units) Table 215. China Atropine Sulfate for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 216. China Atropine Sulfate for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 217. China Atropine Sulfate for Injection Revenue by Application (2021-2026) & (US$ Million) Table 218. China Atropine Sulfate for Injection Revenue by Application (2027-2032) & (US$ Million) Table 219. China Atropine Sulfate for Injection Sales by Application (2021-2026) & (K Units) Table 220. China Atropine Sulfate for Injection Sales by Application (2027-2032) & (K Units) Table 221. China Atropine Sulfate for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 222. China Atropine Sulfate for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 223. Asia Atropine Sulfate for Injection Revenue by Type (2021-2026) & (US$ Million) Table 224. Asia Atropine Sulfate for Injection Revenue by Type (2027-2032) & (US$ Million) Table 225. Asia Atropine Sulfate for Injection Sales by Type (2021-2026) & (K Units) Table 226. Asia Atropine Sulfate for Injection Sales by Type (2027-2032) & (K Units) Table 227. Asia Atropine Sulfate for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 228. Asia Atropine Sulfate for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 229. Asia Atropine Sulfate for Injection Revenue by Application (2021-2026) & (US$ Million) Table 230. Asia Atropine Sulfate for Injection Revenue by Application (2027-2032) & (US$ Million) Table 231. Asia Atropine Sulfate for Injection Sales by Application (2021-2026) & (K Units) Table 232. Asia Atropine Sulfate for Injection Sales by Application (2027-2032) & (K Units) Table 233. Asia Atropine Sulfate for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 234. Asia Atropine Sulfate for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 235. Asia Atropine Sulfate for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. Asia Atropine Sulfate for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. Asia Atropine Sulfate for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. Asia Atropine Sulfate for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 239. Asia Atropine Sulfate for Injection Sales by Country (2021-2026) & (K Units) Table 240. Asia Atropine Sulfate for Injection Sales by Country (2027-2032) & (K Units) Table 241. Asia Atropine Sulfate for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 242. Asia Atropine Sulfate for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 243. Japan Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 244. South Korea Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 245. India Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 246. Australia Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 247. Taiwan Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 248. Southeast Asia Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 249. SAMEA Atropine Sulfate for Injection Revenue by Type (2021-2026) & (US$ Million) Table 250. SAMEA Atropine Sulfate for Injection Revenue by Type (2027-2032) & (US$ Million) Table 251. SAMEA Atropine Sulfate for Injection Sales by Type (2021-2026) & (K Units) Table 252. SAMEA Atropine Sulfate for Injection Sales by Type (2027-2032) & (K Units) Table 253. SAMEA Atropine Sulfate for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 254. SAMEA Atropine Sulfate for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 255. SAMEA Atropine Sulfate for Injection Revenue by Application (2021-2026) & (US$ Million) Table 256. SAMEA Atropine Sulfate for Injection Revenue by Application (2027-2032) & (US$ Million) Table 257. SAMEA Atropine Sulfate for Injection Sales by Application (2021-2026) & (K Units) Table 258. SAMEA Atropine Sulfate for Injection Sales by Application (2027-2032) & (K Units) Table 259. SAMEA Atropine Sulfate for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 260. SAMEA Atropine Sulfate for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 261. SAMEA Atropine Sulfate for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 262. SAMEA Atropine Sulfate for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 263. SAMEA Atropine Sulfate for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 264. SAMEA Atropine Sulfate for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 265. SAMEA Atropine Sulfate for Injection Sales by Country (2021-2026) & (K Units) Table 266. SAMEA Atropine Sulfate for Injection Sales by Country (2027-2032) & (K Units) Table 267. SAMEA Atropine Sulfate for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 268. SAMEA Atropine Sulfate for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 269. Brazil Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 270. Argentina Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 271. Chile Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 272. Colombia Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 273. Peru Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 274. Saudi Arabia Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 275. Israel Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 276. UAE Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 277. Turkey Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 278. Iran Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 279. Egypt Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Table 280. Key Raw Materials Table 281. Raw Materials Key Suppliers Table 282. Atropine Sulfate for Injection Distributors List Table 283. Atropine Sulfate for Injection Customers List Table 284. Research Programs/Design for This Report Table 285. Authors List of This Report Table 286. Secondary Sources Table 287. Primary Sources List of Figures Figure 1. Atropine Sulfate for Injection Image Figure 2. Global Atropine Sulfate for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atropine Sulfate for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.5 mg/mL Image Figure 5. 1 mg/mL Image Figure 6. 5 mg/ml Image Figure 7. Others Image Figure 8. Global Atropine Sulfate for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Atropine Sulfate for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 10. Online Sales Image Figure 11. Offline Sales Image Figure 12. Global Atropine Sulfate for Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Atropine Sulfate for Injection Revenue (2021-2032) & (US$ Million) Figure 14. Global Atropine Sulfate for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Atropine Sulfate for Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Atropine Sulfate for Injection Revenue Market Share by Region (2021-2032) Figure 17. Global Atropine Sulfate for Injection Sales (2021-2032) & (K Units) Figure 18. Global Atropine Sulfate for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Atropine Sulfate for Injection Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Atropine Sulfate for Injection Sales YoY (2021-2032) & (K Units) Figure 21. Europe Atropine Sulfate for Injection Sales YoY (2021-2032) & (K Units) Figure 22. China Atropine Sulfate for Injection Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Atropine Sulfate for Injection Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Atropine Sulfate for Injection Sales YoY (2021-2032) & (K Units) Figure 25. Global Atropine Sulfate for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Atropine Sulfate for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Atropine Sulfate for Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Atropine Sulfate for Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Atropine Sulfate for Injection Revenue Market Share by Type (2021-2032) Figure 31. Global Atropine Sulfate for Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Atropine Sulfate for Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Atropine Sulfate for Injection Sales Market Share by Type (2021-2032) Figure 34. Global Atropine Sulfate for Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Atropine Sulfate for Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Atropine Sulfate for Injection Revenue Market Share by Application (2021-2032) Figure 37. Global Atropine Sulfate for Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Atropine Sulfate for Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Atropine Sulfate for Injection Sales Market Share by Application (2021-2032) Figure 40. North America Atropine Sulfate for Injection Revenue Share by Type (2021-2032) Figure 41. North America Atropine Sulfate for Injection Sales Share by Type (2021-2032) Figure 42. North America Atropine Sulfate for Injection Revenue Share by Application (2021-2032) Figure 43. North America Atropine Sulfate for Injection Sales Share by Application (2021-2032) Figure 44. North America Atropine Sulfate for Injection Revenue Share by Country (2021-2032) Figure 45. North America Atropine Sulfate for Injection Sales Share by Country (2021-2032) Figure 46. Europe Atropine Sulfate for Injection Revenue Share by Type (2021-2032) Figure 47. Europe Atropine Sulfate for Injection Sales Share by Type (2021-2032) Figure 48. Europe Atropine Sulfate for Injection Revenue Share by Application (2021-2032) Figure 49. Europe Atropine Sulfate for Injection Sales Share by Application (2021-2032) Figure 50. Europe Atropine Sulfate for Injection Revenue Share by Country (2021-2032) Figure 51. Europe Atropine Sulfate for Injection Sales Share by Country (2021-2032) Figure 52. China Atropine Sulfate for Injection Revenue Share by Type (2021-2032) Figure 53. China Atropine Sulfate for Injection Sales Share by Type (2021-2032) Figure 54. China Atropine Sulfate for Injection Revenue Share by Application (2021-2032) Figure 55. China Atropine Sulfate for Injection Sales Share by Application (2021-2032) Figure 56. Asia Atropine Sulfate for Injection Revenue Share by Type (2021-2032) Figure 57. Asia Atropine Sulfate for Injection Sales Share by Type (2021-2032) Figure 58. Asia Atropine Sulfate for Injection Revenue Share by Application (2021-2032) Figure 59. Asia Atropine Sulfate for Injection Sales Share by Application (2021-2032) Figure 60. Asia Atropine Sulfate for Injection Revenue Share by Country (2021-2032) Figure 61. Asia Atropine Sulfate for Injection Sales Share by Country (2021-2032) Figure 62. SAMEA Atropine Sulfate for Injection Revenue Share by Type (2021-2032) Figure 63. SAMEA Atropine Sulfate for Injection Sales Share by Type (2021-2032) Figure 64. SAMEA Atropine Sulfate for Injection Revenue Share by Application (2021-2032) Figure 65. SAMEA Atropine Sulfate for Injection Sales Share by Application (2021-2032) Figure 66. SAMEA Atropine Sulfate for Injection Revenue Share by Country (2021-2032) Figure 67. SAMEA Atropine Sulfate for Injection Sales Share by Country (2021-2032) Figure 68. Atropine Sulfate for Injection Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Atropine Sulfate for Injection Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5 mg/mL
  • 1 mg/mL
  • 5 mg/ml
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Accord Healthcare
  • American Regent
  • Amneal Pharmaceuticals
  • Apotex
  • Hikma Pharmaceuticals
  • Anhui Changjiang Pharmaceutical
  • Changzhou Pharmaceutical Factory
  • Chengdu Brilliant Pharmaceutical
  • Hebei Kaiwei Pharmaceutical
  • Hebei Tiancheng Pharmaceutical
  • Hubei Xinghua Pharmaceutical
  • China Res Double-Crane
  • Pfizer
  • Sunflower Pharmaceutical
  • Shanghai Harvest Pharmaceutical
  • China Shineway Pharm
  • CSPC Ouyi Pharmaceutical
  • Suicheng Pharmaceutical
  • Tai Yu Chemical & Pharmaceutical
  • Tianjin Jinyao Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Atropine Sulfate for Injection Market by Type
  3. 1.2.1 Global Atropine Sulfate for Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.5 mg/mL
  5. 1.2.3 1 mg/mL
  6. 1.2.4 5 mg/ml
  7. 1.2.5 Others
  8. 1.3 Atropine Sulfate for Injection Market by Application
  9. 1.3.1 Global Atropine Sulfate for Injection Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Online Sales
  11. 1.3.3 Offline Sales
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Atropine Sulfate for Injection Market Dynamics
  1. 2.1 Atropine Sulfate for Injection Industry Trends
  2. 2.2 Atropine Sulfate for Injection Industry Drivers
  3. 2.3 Atropine Sulfate for Injection Industry Opportunities and Challenges
  4. 2.4 Atropine Sulfate for Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Atropine Sulfate for Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Atropine Sulfate for Injection Revenue by Region
  3. 3.2.1 Global Atropine Sulfate for Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Atropine Sulfate for Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Atropine Sulfate for Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Atropine Sulfate for Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Atropine Sulfate for Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Atropine Sulfate for Injection Sales by Region
  9. 3.4.1 Global Atropine Sulfate for Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Atropine Sulfate for Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Atropine Sulfate for Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Atropine Sulfate for Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Atropine Sulfate for Injection Revenue by Manufacturers
  2. 4.1.1 Global Atropine Sulfate for Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Atropine Sulfate for Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Atropine Sulfate for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Atropine Sulfate for Injection Sales by Manufacturers
  6. 4.2.1 Global Atropine Sulfate for Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Atropine Sulfate for Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Atropine Sulfate for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Atropine Sulfate for Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Atropine Sulfate for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Atropine Sulfate for Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Atropine Sulfate for Injection Manufacturers, Product Type & Application
  13. 4.7 Global Atropine Sulfate for Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Atropine Sulfate for Injection Market CR5 and HHI
  16. 4.8.2 2025 Atropine Sulfate for Injection Tier 1, Tier 2, and Tier 3
5 Atropine Sulfate for Injection Market by Type
  1. 5.1 Global Atropine Sulfate for Injection Revenue by Type
  2. 5.1.1 Global Atropine Sulfate for Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Atropine Sulfate for Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Atropine Sulfate for Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Atropine Sulfate for Injection Sales by Type
  6. 5.2.1 Global Atropine Sulfate for Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Atropine Sulfate for Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Atropine Sulfate for Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Atropine Sulfate for Injection Price by Type
6 Atropine Sulfate for Injection Market by Application
  1. 6.1 Global Atropine Sulfate for Injection Revenue by Application
  2. 6.1.1 Global Atropine Sulfate for Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Atropine Sulfate for Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Atropine Sulfate for Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Atropine Sulfate for Injection Sales by Application
  6. 6.2.1 Global Atropine Sulfate for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Atropine Sulfate for Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Atropine Sulfate for Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Atropine Sulfate for Injection Price by Application
7 Company Profiles
  1. 7.1 Accord Healthcare
  2. 7.1.1 Accord Healthcare Company Information
  3. 7.1.2 Accord Healthcare Business Overview
  4. 7.1.3 Accord Healthcare Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Accord Healthcare Atropine Sulfate for Injection Product Portfolio
  6. 7.1.5 Accord Healthcare Recent Developments
  7. 7.2 American Regent
  8. 7.2.1 American Regent Company Information
  9. 7.2.2 American Regent Business Overview
  10. 7.2.3 American Regent Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 American Regent Atropine Sulfate for Injection Product Portfolio
  12. 7.2.5 American Regent Recent Developments
  13. 7.3 Amneal Pharmaceuticals
  14. 7.3.1 Amneal Pharmaceuticals Company Information
  15. 7.3.2 Amneal Pharmaceuticals Business Overview
  16. 7.3.3 Amneal Pharmaceuticals Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Amneal Pharmaceuticals Atropine Sulfate for Injection Product Portfolio
  18. 7.3.5 Amneal Pharmaceuticals Recent Developments
  19. 7.4 Apotex
  20. 7.4.1 Apotex Company Information
  21. 7.4.2 Apotex Business Overview
  22. 7.4.3 Apotex Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Apotex Atropine Sulfate for Injection Product Portfolio
  24. 7.4.5 Apotex Recent Developments
  25. 7.5 Hikma Pharmaceuticals
  26. 7.5.1 Hikma Pharmaceuticals Company Information
  27. 7.5.2 Hikma Pharmaceuticals Business Overview
  28. 7.5.3 Hikma Pharmaceuticals Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hikma Pharmaceuticals Atropine Sulfate for Injection Product Portfolio
  30. 7.5.5 Hikma Pharmaceuticals Recent Developments
  31. 7.6 Anhui Changjiang Pharmaceutical
  32. 7.6.1 Anhui Changjiang Pharmaceutical Company Information
  33. 7.6.2 Anhui Changjiang Pharmaceutical Business Overview
  34. 7.6.3 Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Product Portfolio
  36. 7.6.5 Anhui Changjiang Pharmaceutical Recent Developments
  37. 7.7 Changzhou Pharmaceutical Factory
  38. 7.7.1 Changzhou Pharmaceutical Factory Company Information
  39. 7.7.2 Changzhou Pharmaceutical Factory Business Overview
  40. 7.7.3 Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Product Portfolio
  42. 7.7.5 Changzhou Pharmaceutical Factory Recent Developments
  43. 7.8 Chengdu Brilliant Pharmaceutical
  44. 7.8.1 Chengdu Brilliant Pharmaceutical Company Information
  45. 7.8.2 Chengdu Brilliant Pharmaceutical Business Overview
  46. 7.8.3 Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Product Portfolio
  48. 7.8.5 Chengdu Brilliant Pharmaceutical Recent Developments
  49. 7.9 Hebei Kaiwei Pharmaceutical
  50. 7.9.1 Hebei Kaiwei Pharmaceutical Company Information
  51. 7.9.2 Hebei Kaiwei Pharmaceutical Business Overview
  52. 7.9.3 Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Product Portfolio
  54. 7.9.5 Hebei Kaiwei Pharmaceutical Recent Developments
  55. 7.10 Hebei Tiancheng Pharmaceutical
  56. 7.10.1 Hebei Tiancheng Pharmaceutical Company Information
  57. 7.10.2 Hebei Tiancheng Pharmaceutical Business Overview
  58. 7.10.3 Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Product Portfolio
  60. 7.10.5 Hebei Tiancheng Pharmaceutical Recent Developments
  61. 7.11 Hubei Xinghua Pharmaceutical
  62. 7.11.1 Hubei Xinghua Pharmaceutical Company Information
  63. 7.11.2 Hubei Xinghua Pharmaceutical Business Overview
  64. 7.11.3 Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Product Portfolio
  66. 7.11.5 Hubei Xinghua Pharmaceutical Recent Developments
  67. 7.12 China Res Double-Crane
  68. 7.12.1 China Res Double-Crane Company Information
  69. 7.12.2 China Res Double-Crane Business Overview
  70. 7.12.3 China Res Double-Crane Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 China Res Double-Crane Atropine Sulfate for Injection Product Portfolio
  72. 7.12.5 China Res Double-Crane Recent Developments
  73. 7.13 Pfizer
  74. 7.13.1 Pfizer Company Information
  75. 7.13.2 Pfizer Business Overview
  76. 7.13.3 Pfizer Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Pfizer Atropine Sulfate for Injection Product Portfolio
  78. 7.13.5 Pfizer Recent Developments
  79. 7.14 Sunflower Pharmaceutical
  80. 7.14.1 Sunflower Pharmaceutical Company Information
  81. 7.14.2 Sunflower Pharmaceutical Business Overview
  82. 7.14.3 Sunflower Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Sunflower Pharmaceutical Atropine Sulfate for Injection Product Portfolio
  84. 7.14.5 Sunflower Pharmaceutical Recent Developments
  85. 7.15 Shanghai Harvest Pharmaceutical
  86. 7.15.1 Shanghai Harvest Pharmaceutical Company Information
  87. 7.15.2 Shanghai Harvest Pharmaceutical Business Overview
  88. 7.15.3 Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Product Portfolio
  90. 7.15.5 Shanghai Harvest Pharmaceutical Recent Developments
  91. 7.16 China Shineway Pharm
  92. 7.16.1 China Shineway Pharm Company Information
  93. 7.16.2 China Shineway Pharm Business Overview
  94. 7.16.3 China Shineway Pharm Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 China Shineway Pharm Atropine Sulfate for Injection Product Portfolio
  96. 7.16.5 China Shineway Pharm Recent Developments
  97. 7.17 CSPC Ouyi Pharmaceutical
  98. 7.17.1 CSPC Ouyi Pharmaceutical Company Information
  99. 7.17.2 CSPC Ouyi Pharmaceutical Business Overview
  100. 7.17.3 CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Product Portfolio
  102. 7.17.5 CSPC Ouyi Pharmaceutical Recent Developments
  103. 7.18 Suicheng Pharmaceutical
  104. 7.18.1 Suicheng Pharmaceutical Company Information
  105. 7.18.2 Suicheng Pharmaceutical Business Overview
  106. 7.18.3 Suicheng Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Suicheng Pharmaceutical Atropine Sulfate for Injection Product Portfolio
  108. 7.18.5 Suicheng Pharmaceutical Recent Developments
  109. 7.19 Tai Yu Chemical & Pharmaceutical
  110. 7.19.1 Tai Yu Chemical & Pharmaceutical Company Information
  111. 7.19.2 Tai Yu Chemical & Pharmaceutical Business Overview
  112. 7.19.3 Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Product Portfolio
  114. 7.19.5 Tai Yu Chemical & Pharmaceutical Recent Developments
  115. 7.20 Tianjin Jinyao Pharmaceutical
  116. 7.20.1 Tianjin Jinyao Pharmaceutical Company Information
  117. 7.20.2 Tianjin Jinyao Pharmaceutical Business Overview
  118. 7.20.3 Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Product Portfolio
  120. 7.20.5 Tianjin Jinyao Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Atropine Sulfate for Injection Market Size by Type
  2. 8.1.1 North America Atropine Sulfate for Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Atropine Sulfate for Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Atropine Sulfate for Injection Price by Type (2021-2032)
  5. 8.2 North America Atropine Sulfate for Injection Market Size by Application
  6. 8.2.1 North America Atropine Sulfate for Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Atropine Sulfate for Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Atropine Sulfate for Injection Price by Application (2021-2032)
  9. 8.3 North America Atropine Sulfate for Injection Market Size by Country
  10. 8.3.1 North America Atropine Sulfate for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Atropine Sulfate for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Atropine Sulfate for Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Atropine Sulfate for Injection Market Size by Type
  2. 9.1.1 Europe Atropine Sulfate for Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Atropine Sulfate for Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Atropine Sulfate for Injection Price by Type (2021-2032)
  5. 9.2 Europe Atropine Sulfate for Injection Market Size by Application
  6. 9.2.1 Europe Atropine Sulfate for Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Atropine Sulfate for Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Atropine Sulfate for Injection Price by Application (2021-2032)
  9. 9.3 Europe Atropine Sulfate for Injection Market Size by Country
  10. 9.3.1 Europe Atropine Sulfate for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Atropine Sulfate for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Atropine Sulfate for Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Atropine Sulfate for Injection Market Size by Type
  2. 10.1.1 China Atropine Sulfate for Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Atropine Sulfate for Injection Sales by Type (2021-2032)
  4. 10.1.3 China Atropine Sulfate for Injection Price by Type (2021-2032)
  5. 10.2 China Atropine Sulfate for Injection Market Size by Application
  6. 10.2.1 China Atropine Sulfate for Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Atropine Sulfate for Injection Sales by Application (2021-2032)
  8. 10.2.3 China Atropine Sulfate for Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Atropine Sulfate for Injection Market Size by Type
  2. 11.1.1 Asia Atropine Sulfate for Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Atropine Sulfate for Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Atropine Sulfate for Injection Price by Type (2021-2032)
  5. 11.2 Asia Atropine Sulfate for Injection Market Size by Application
  6. 11.2.1 Asia Atropine Sulfate for Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Atropine Sulfate for Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Atropine Sulfate for Injection Price by Application (2021-2032)
  9. 11.3 Asia Atropine Sulfate for Injection Market Size by Country
  10. 11.3.1 Asia Atropine Sulfate for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Atropine Sulfate for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Atropine Sulfate for Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Atropine Sulfate for Injection Market Size by Type
  2. 12.1.1 SAMEA Atropine Sulfate for Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Atropine Sulfate for Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Atropine Sulfate for Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Atropine Sulfate for Injection Market Size by Application
  6. 12.2.1 SAMEA Atropine Sulfate for Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Atropine Sulfate for Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Atropine Sulfate for Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Atropine Sulfate for Injection Market Size by Country
  10. 12.3.1 SAMEA Atropine Sulfate for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Atropine Sulfate for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Atropine Sulfate for Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Atropine Sulfate for Injection Value Chain Analysis
  2. 13.1.1 Atropine Sulfate for Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Atropine Sulfate for Injection Production Mode & Process
  6. 13.2 Atropine Sulfate for Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Atropine Sulfate for Injection Distributors
  9. 13.2.3 Atropine Sulfate for Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst